Dodd, Dylan
- Stanford University · Pathology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #9,727
- Rising Star
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pathology
NIH Funding · FY2023
Linked Award Amount
$1M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#9,727
By linked amount among FY2023 PIs
Earliest Year Loaded
2009
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Dodd, Dylan as a PI. Multi-PI records show the full award amount for context.
- 5R01AT011396-02R01Contact PIMicrobiota-based probiotics to treat inborn errors in metabolismStanford University · Pathology (NIH department code)$587.9Kaward amount
- 5R35GM142873-03R35Contact PIPhysiology of bacterial metabolism in the human gut microbiomeStanford University · Pathology (NIH department code)$397.3Kaward amount
- 3R35GM142873-02S1R35Contact PIPhysiology of bacterial metabolism in the human gut microbiomeStanford University · Pathology (NIH department code)$48Kaward amount
Award organization
Organizations that administered FY2023 awards listing Dodd, Dylan as a PI.
FY2023 award administered by Stanford University (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardStanford University
- 2013R01 Grant Holder
- 2020$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2022$2M Cumulative Funding
- 2023Entered Top 50% NationallyRanked #9727